The Wiedemann-Rautenstrauch syndrome (WRS) is a rare progeroid syndrome (PS), first coined in 1981 by Devos et al. (
1), following the presentation of four patients with similar characteristics by Rautenstrauch and Singula in two sisters and Wiedemann in two unrelated patients in 1979 (
2,
3). PSs are rare genetic disorders mimicking the clinical and molecular features of aging. The underlying pathophysiology of such disorders is a mutation in genes encoding either DNA repair proteins or the lamin A/C (LMNA) (
4). The etiology of WRS remains unknown (
5). The inheritance pattern is supposed to be autosomal recessive (AR), although specific genes are not identified (
6). Mutations of the LMNA gene were not found in four clinically well-characterized WRS patients, and recessive mutations of a different gene are speculated on as the cause of this disorder (
7). It is not confirmed that the LMNA, ERCC8, or ZMPSTE24 mutations account for WRS either (
8). Wambach et al. (
9), suggested that bi-allelic, POLR3A variants altering splicing and/or truncate translation underlie the autosomal-recessive subtype of WRS. At present, molecular researches on the determination of particular mutations, involvement of modulator genes, additional mutations, and polymorphisms of POLR3A, which might lead to WRS, are in progress.
WRS has a vast phenotypic variability (
10); however, the similarity of the reported cases is high enough to make a proper diagnosis (
11).
WRS, also known as the neonatal progeroid syndrome (NPS), differs from other progerias in the complex of signs and symptoms present at birth (
12). Core clinical signs include severe intrauterine and postnatal growth failure, hydrocephaly, prominent scalp veins, sparse hair of the scalp, eyebrows, and eyelashes, generalized lipoatrophy, psychomotor delay, and progressive neurological deterioration. Natal teeth and micrognathia are also reported in some cases (
13).